4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-24-012734
Chief Product Strategy Officer sold 7,266 shares at $12.33 ($89,590)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kieffer Tara Lynn Chief Product Strategy Officer | 2024-06-17 | Sale 10b5-1 | −7,266 | $12.33 | $89,590 | 32,341 | D |
| Open-market sales · 7,266 sh · avg $12.33 · $89,590 | |||||||
Loading xslF345X05/form4.xml…